Prosecution Insights
Last updated: April 19, 2026
Application No. 17/280,222

BALLOON ENCAPSULATION AND ISOVOLUMETRIC SUCTION THROMBECTOMY CATHETER AND METHODS THEREOF

Non-Final OA §112
Filed
Mar 26, 2021
Examiner
MCGINNITY, JAMES RYAN
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Washington University
OA Round
5 (Non-Final)
56%
Grant Probability
Moderate
5-6
OA Rounds
3y 3m
To Grant
99%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allow Rate
52 granted / 93 resolved
-14.1% vs TC avg
Strong +50% interview lift
Without
With
+50.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
50 currently pending
Career history
143
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
46.7%
+6.7% vs TC avg
§102
29.7%
-10.3% vs TC avg
§112
19.4%
-20.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 93 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment The claims filed on January 28th, 2026, have been entered. Claims 1-3, 6, 8-13, 17-18, and 20-21 remain pending in the Application. Response to Arguments Applicant's arguments filed January 28th, 2026, have been fully considered but they are not persuasive. The claim amendment requiring that “the agitator has a fixed shape” overcomes the previously presented 35 USC 103 rejections over Mische in view of Sos. However, this limitation comprises new matter and has been rejected under 112(a). Applicant also argues that the combination of Mische et al. (U.S. Patent No. 5,279,546) and Sos (Pub. No. 2016/0367285) is improper because Mische et al. creates an isolated treatment area using two balloons while maintaining safe pressure levels within the area, and teaches away from using any kind of expansion system, such as the macerator 200 of Sos, within the treatment area with the discussion of the middle balloon in the system of Baran (C1:63-C2:L2). Examiner respectfully disagrees with this particular argument. Mische et al. does teach away from the additional balloon in Baran, as a balloon inflating in an otherwise closed treatment area will necessarily increase the pressure in the treatment area and could rupture arterial walls. However, the macerator wires of Sos, as shown in FIG. 11, do not cover a substantial volume, and while they expand and contract, the expansion and contraction does not change the amount of volume that the wires occupy, in contrast to a balloon. Therefore, using the macerator 200 of Sos within the treatment area established by Mische et al. would not lead to the problems discussed in Mische et al. with a middle third balloon. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1-3, 6, 8-13, 17-18, and 20-21 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 1 has been amended to include the limitation “wherein the agitator has a fixed shape”. The term “fixed” or a synonym does not appear in the present Specification at all, and Applicant did not point to any disclosures which supported the amendment in their Remarks, which forced the Examiner to look for evidence that the amendment was supported by the Specification. However, the Specification teaches away from the agitator comprising a fixed shape. For example, [00102] states that “the agitator may be connected to the inner catheter which runs along the catheter lumen of the outer sheath by three wires, connected on the left, right, and bottom planes of the agitator. This allows for flexibility in the overall catheter system, as the agitator is able to ride along bends made in the catheter.” For the agitator to travel along the bends, the agitator must be able to bend and flex, which would constitute changes in the shape of the agitator. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JAMES RYAN MCGINNITY whose telephone number is (571)272-0573. The examiner can normally be reached M-Th 8 am-5:30 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at 571-272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JRM/Examiner, Art Unit 3771 /KATHLEEN S HOLWERDA/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Mar 26, 2021
Application Filed
Mar 31, 2023
Response after Non-Final Action
Dec 11, 2023
Non-Final Rejection — §112
Jun 14, 2024
Response Filed
Sep 05, 2024
Final Rejection — §112
Feb 05, 2025
Request for Continued Examination
Feb 06, 2025
Response after Non-Final Action
Feb 24, 2025
Non-Final Rejection — §112
Sep 04, 2025
Response Filed
Nov 24, 2025
Final Rejection — §112
Jan 28, 2026
Response after Non-Final Action
Feb 06, 2026
Request for Continued Examination
Feb 18, 2026
Response after Non-Final Action
Mar 11, 2026
Non-Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594067
ROTARY STITCHING DEVICE
2y 5m to grant Granted Apr 07, 2026
Patent 12551279
LITHOTRIPSY BALLOON CATHETER
2y 5m to grant Granted Feb 17, 2026
Patent 12514585
ADHESION PROMOTION DEVICE
2y 5m to grant Granted Jan 06, 2026
Patent 12478508
TUBE DEPLOYING SYSTEM
2y 5m to grant Granted Nov 25, 2025
Patent 12458361
OCCLUSIVE DEVICES WITH SPIRAL STRUTS FOR TREATING VASCULAR DEFECTS
2y 5m to grant Granted Nov 04, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
56%
Grant Probability
99%
With Interview (+50.4%)
3y 3m
Median Time to Grant
High
PTA Risk
Based on 93 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month